Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Circulation|November 1, 1995
Generation of tumor-specific T lymphocytes for the treatment of posttransplant lymphomaJ M DiMaio, P Van Trigt, J W Gaynor, et al.
Molecular Cancer Therapeutics|January 19, 2008
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionKatherine M Aird, Xiuyun Ding, Aris Baras, et al.
The Journal of Experimental Medicine|October 1, 1992
Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replicationM H Malim, W W Freimuth, J Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery systemB M Clary, E C Coveney, D G Blazer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancerR Philip, B Clary, E Brunette, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1989
GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibodyD S Tyler, C L Nastala, S D Stanley, et al.
Journal of Virology|October 1, 1993
Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytesK R Berend, J U Jung, T J Boyle, et al.
Pageof 10